Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Citric acid 334mg/Pot cit 550mg/Sod cit 500mg/5ml soln
070403000AAAGAG
|
Generic compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | 24 |
|
Rowatinex capsules
070403000BPBBA0
|
Proprietary compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | 6 |
|
Ammonium chloride 325mg / Caffeine 100mg gast res tab
070403000AAAFAF
|
Generic compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Aqua Ban gastro-resistant tablets
070403000BPBAAF
|
Proprietary compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Cystitis Relief effervescent tablets
070403000BPBEA0
|
Proprietary compound preparation BNF 0704030 | Other urological pain preparations | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.